From Liver Diseases to Cancer Care,
Driving Asia's Biotech Breakthroughs

Medigen Biotechnology Corp. upholds the vision of “Innovations for a Better Life” with a strong commitment to addressing major diseases such as liver disorders and cancer. Our business portfolio spans new drug development, molecular diagnostics, vaccine technologies, and generic medicines, as we strive to become a leading integrated biomedical group in Asia.